[Correlation between hepatitis B virus infection and chronic liver disease in Okinawa]

H Sakugawa1

  • 1First Department of Internal Medicine, University Hospital, Faculty of Medicine, University of the Ryukyus.

Insights

Okinawa has the highest prevalence of hepatitis B surface antigen (HBsAg) in Japan, yet the lowest liver disease mortality. Studies suggest a lower HBsAg positivity rate in Okinawan patients with liver cirrhosis and liver cancer, indicating a unique epidemiological profile.

Area of Science:

  • Hepatology
  • Epidemiology
  • Virology

Context:

  • Okinawa prefecture exhibits a high prevalence of hepatitis B surface antigen (HBsAg) carriers (3.5%) compared to the Japanese average (1.5%).
  • Despite high HBsAg prevalence, Okinawa reports the lowest mortality rates for liver cirrhosis (LC) and primary liver cancer (PLC) in Japan.
  • This presents a discrepancy with established epidemiological correlations between HBsAg positivity and PLC mortality.

Purpose:

  • To investigate the reasons behind the epidemiological paradox in Okinawa regarding hepatitis B virus (HBV) infection and liver disease outcomes.
  • To analyze HBsAg prevalence, hepatitis B e antigen (HBeAg) positivity, and clinical outcomes in Okinawan populations.

Summary:

  • Cross-sectional studies revealed lower HBsAg rates in Okinawan patients with LC (15.2%) and hepatocellular carcinoma (24.4%) compared to national averages.
  • Age-specific HBeAg positivity decreased significantly with age, with most HBsAg carriers showing anti-HBe antibodies and normal liver enzymes.
  • A prospective study identified a high proportion of healthy HBsAg carriers (88.4%) with minimal liver damage among referred individuals.

Impact:

  • Findings suggest that the high HBsAg prevalence in Okinawa may represent a population with a high proportion of healthy carriers and lower rates of HBV-related liver disease.
  • This research contributes to understanding the diverse clinical spectrum of HBV infection and its epidemiological variations.
  • Highlights the importance of considering host factors and HBV genotypes in assessing liver disease risk.

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...